Stock HOWL WEREWOLF THERAPEUTICS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Transcripts Werewolf Therapeutics, Inc.

Equities

HOWL

US95075A1079

Delayed Nasdaq
Other stock markets
 12:55:10 2024-06-05 pm EDT 		5-day change 1st Jan Change
3.577 USD -1.72% Intraday chart for Werewolf Therapeutics, Inc. -29.72% -7.32%
Jun. 01 Werewolf Therapeutics to Present Data from Ongoing Phase 1/1B Clinical Trial of WTX-124 as Monotherapy and in Combination with Pembrolizumab in Solid Tumors CI
May. 23 Werewolf Therapeutics to Present Updated Data from Phase 1/1b Clinical Trial of WTX-124 as Monotherapy and in Combination with Pembrolizumab in Solid Tumors at 2024 ASCO Annual Meeting CI

Transcripts

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. HOWL Stock
  4. News Werewolf Therapeutics, Inc.
  5. Transcripts